Geron
GERN
#6503
Rank
NZ$1.33 B
Marketcap
NZ$2.08
Share price
-1.22%
Change (1 day)
-11.15%
Change (1 year)

EPS for Geron (GERN)

EPS in 2025 (TTM): NZ-$0.22

According to Geron's latest financial reports the company's current EPS (TTM) is NZ-$0.22. In 2024 the company made an earnings per share (EPS) of NZ-$0.46 an increase over its 2023 EPS that were of NZ-$0.57.

EPS history for Geron from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.22-51.63%
2024NZ-$0.46-18.18%
2023NZ-$0.57-8.33%
2022NZ-$0.62-0%
2021NZ-$0.6233.33%
2020NZ-$0.46-25%
2019NZ-$0.62140%
2018NZ-$0.26-16.67%
2017NZ-$0.31-0%
2016NZ-$0.31-1.2970366926827E+18%
2015NZ$0.0000000000-100%
2014NZ-$0.41
2012NZ-$0.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$11.74-5,369.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$12.51-5,715.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ-$0.99 346.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$1.22-646.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$131.47 58,907.69%๐Ÿ‡บ๐Ÿ‡ธ USA